Page 120 - 《中国药科大学学报》2026年第1期

114 学报 Journal of China Pharmaceutical University 2026, 57(1): 108 − 114 第 57 卷

究和完善：比如一些陈旧方法的优化，标准品的量 [16] Yao YQ, Gao JD, Liu Y. Investigation of test organisms and
media for microbiological assay of antibiotics[J]. World Notes
效统一。更值得一提的是目前对于多组分抗生素
Antibiot (国外医药 抗生素分册), 2019, 40(4): 380-385.
而言，其成分复杂，难以用单一化学指标衡量。微 [17] Ren ZL, Zhang XH, Wang J, et al. Research progress of the in-
生物检定法以基于整体生物活性的“效价”为单位， fluencing factors and control methods for the determination of
antibiotic potency by the cylinder-plate method[J]. China Mod
能够最真实、最综合地评价其实际药效强度，目前 Med (中国当代医药), 2020, 27(25): 27-29,33.
仍是各国法定的仲裁方法和标准方法。那么如何 [18] Chang Y, Yao SC, Hu CQ. Common factors affecting the re-
sults' accuracy of the microbiological assay for antibiotics(the
在控制效价的同时，对其组分进行有效的评价，以
agar diffusion method)[J]. Chin J Antibiot (中国抗生素杂志),
保证标准品不同批次之间的溯源性和稳定性也是 2018, 43(7): 875-880.
值得研究的课题。 [19] Wang LX, Ma BF, Zhang PP, et al. Improvement of microbio-
logical potency measurement of tetraenes antifungal
antibiotics[J]. Chin J Antibiot (中国抗生素杂志), 2023, 48(7):
References 778-785.
[20] Chang Y, Yao SC, Hu CQ. The important changes of Pharma-
[1] Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia: copoeia of the People’s Republic of China 2015 on gentamicin
part 4(中华人民共和国药典: 四部)[S]. Beijing: China Medi- sulfate monograph, the content of gentamicins C from the rela-
cal Science Press, 2025: 53. tive content to the absolute level[J]. Chin J Antibiot (中国抗生
[2] Bi RR, Zhou Y, Liu YF, et al. Development and establishment 素杂志), 2016, 41(1): 1-15.
of antibiotic standard in China[J]. Infect Dis Inf (传染病信息),
[21] Liu M, Hu CQ. Simultaneous determination of the purity and
1994, 7(2): 56, 88.
potency of vancomycin and norvancomycin by HPLC[J]. Chro-
[3] Feng YC, Pei WL, Ning BM, et al. Development and applica- matographia, 2007, 65(3): 203-207.
tion of chemical reference materials[J]. J China Pharm Univ (中 [22] Chang Y, Wang YH, Hu CQ. Simultaneous determination of
国药科大学学报), 2024, 55(5): 715-720. purity and potency of amphotericin B by HPLC[J]. J Antibiot,
[4] Qiu Y, Liu H, Yang MC. An introduction to the amendments of 2011, 64(11): 735-739.
antibiotic standards in Pharmacopoeia of the People’s Republic [23] Huang MW, Hou YR, Zhang Q, et al. Transition of determina-
of China(2015 version) volume II[J]. Shanghai Med Pharm J tion method of potency of neomycin sulfate from microbiologi-
(上海医药), 2016, 37(7): 5-8. cal assay to HPLC-PAD[J]. Chin Pharm J (中国药学杂志),
[5] Hu CQ. Antibiotic Reference Substance(抗生素标准物质)[M]. 2020, 55(2): 133-140.
Beijing: Chemical Industry Press, 2024. [24] Fedorenko V, Genilloud O, Horbal L, et al. Antibacterial dis-
[6] Hu CQ, Liu W. Microbiological assay of antibiotics and its covery and development: from gene to product and back[J].
standard operation(抗生素微生物检定法及其标准操作)[M]. Biomed Res Int, 2015, 2015: 591349.
Beijing: China Meteorological Press, 2004. [25] Zhao M, Fan J, Bo JX. Studies on sagamicin produced by M.
[7] Yang YL, Yang JN, Hu M, et al. Determination of the compo- echinospora II. mutant strain selection and fermentation of M.
nents of bitespiramycin by HPLC[J]. Acta Pharm Sin (药学学 echinospora JIM-401[J]. Chin J Antibiot(中国抗生素杂志),
报), 2009, 44(10): 1183-1186. 1984, 9(2): 8-11.
[8] Hu CQ, Liu M, Shao RG, et al. Definition of potency unit of li- [26] Zhao M, Fan J, Bo JX, et al. Studies on the sagamicin produced
damycin and establishment of the potency determination by Micromonospora echinospora mutant strain: i. taxonomical
method[J]. Chin J Pharm Anal (药物分析杂志), 2004, 24(5): identification of m. echinospora Jim-401[J]. Chin J Antibiot (抗
543-546. 生素), 1983, 8(5): 285-289.
[9] Cheng SH, Yin LH, Hu CQ. Establishment of national refer- [27] Vézina C, Bolduc C, Kudelski A, et al. Biosynthesis of ki-
ence standard of dirithromycin[J]. Chin J Antibiot (中国抗生素 tasamycin (leucomycin) by leucine analog-resistant mutants of
杂志), 2002, 27(1): 36-38. Streptomyces kitasatoensis[J]. Antimicrob Agents Chemother,
[10] Yang YL, Jin SH. Advances in quality analysis of antimicrobial 1979, 15(5): 738-746.
agents[J]. Chin J Antibiot(中国抗生素杂志), 2002, 27(8): 508- [28] Zhao PP, Qie LP, Ma J, et al. Breeding of teicoplanin high-yield
512. strain from actinomycetes and optimization of fermentation con-
[11] Zhang ZD. Antibiotic drug inspection(抗生素药品检验)[M]. ditions[J]. Chin J Antibiot (中国抗生素杂志), 2022, 47(6): 569-
Beijing: People's Medical Publishing House, 1987: 381. 574.
[12] Cai YY, Lee W, Kwa AL. Polymyxin B versus colistin: an up- [29] Waitz JA, Moss EL Jr, Oden EM, et al. Biological activity of
date[J]. Expert Rev Anti Infect Ther, 2015, 13(12): 1481-1497. Sch 14342, an aminoglycoside antibiotic coproduced in the gen-
[13] Falagas ME, Kasiakou SK. Use of international units when dos- tamicin fermentation[J]. Antimicrob Agents Chemother, 1972,
ing colistin will help decrease confusion related to various for- 2(6): 464-469.
mulations of the drug around the world[J]. Antimicrob Agents [30] Ma BF, Wang LX, Zhang PP, et al. Possible impact on consis-
Chemother, 2006, 50(6): 2274-2275. tency evaluation of multi-component antibiotic injections by do-
[14] Lightbown JW, Bond JM, Grab B. The international standard mestic and international differences in the quality control[J].
for colistin[J]. Bull World Health Organ, 1973, 48(1): 65-74. Chin J Antibiot (中国抗生素杂志), 2022, 47(8): 808-815.
[15] Niu XS, Hu CQ, Chang Y. History and status of development of [31] Hu CQ, Yao SC, Feng YC. Development and concerns on an-
polymyxin antibiotics[J]. China Pharm (中国药师), 2021, tibiotic specifications[J]. Chin J Antibiot (中国抗生素杂志),
24(5): 936-940. 2025, 50(3): 241-255.